Introduction {#S1}
============

Horizontal gene transfer by conjugation is ubiquitous among microorganisms belonging to the kingdoms of bacteria and archaea. If a transfer competent cell harboring a mobile genetic element contacts a recipient in a suitable environment, subsequent transfer of genetic information can decisively expand the metabolic, resistance, or virulence capabilities of the recipient bacterium. In canonical conjugation systems, single-stranded DNA is transported unidirectionally by means of a cell envelope-spanning multi-protein transport complex \[termed type IV secretion system (T4SS)\]. The process of DNA transfer through the T4SS is ATP dependent and coupled to DNA replication. Mechanistic and structural aspects are detailed in excellent recent reviews ([@B28]; [@B2]; [@B29]; [@B25]). The transported DNA is usually guided by at least one protein and derived from an autonomously replicating conjugative plasmid (CP) or from an integrating conjugative element (ICE). Importantly, additional cargo genes integrated into the mobile DNA element can rapidly spread throughout bacterial populations.

Within the *Enterobacteriaceae*, F-like plasmids are highly prevalent and have been found to be frequently associated with a variety of cargo genes such as antibiotic, biocide, and metal resistance genes. In addition, colicin and microcin genes as well as virulence and enterotoxin genes can be present, providing advantageous traits to their hosts ([@B9]). Due to the presence of a common backbone with DNA transfer, replication, toxin-antitoxin, and partitioning genes, this group of CPs represent highly successful mobile genetic elements that spread and persist in many enterobacterial species and importantly also in pathogenic strains of *Escherichia coli* (for a recent review, see [@B9]). Based on a classification scheme for CPs, F-like plasmids with the classical F plasmid or the antibiotic resistance plasmid R1 belong to the MOB~F12~A group. They harbor conjugation genes that are phylogenetically related and share a similar arrangement ([@B5]; [@B9]; [Figure 1A](#F1){ref-type="fig"}). Nine subgroups have been defined within the MOB~F12~A based on the amino acid sequence variability of the DNA transfer gene activator TraJ ([@B9]).

![**(A)** Schematic representation of the DNA transfer region of F-like MOB~F12~A plasmids. DNA transfer (*tra*) genes are indicated by capital letters inside the boxes. *oriT* is the origin of DNA transfer, representing a DNA region where several DNA binding proteins such as TraM, TraY, and TraI (the relaxase-helicase) bind. *nic* denotes the nick site which is recognized by the relaxase for the initiation of ssDNA transfer into recipients via a T4SS. Arrows indicate known promoters. P~Y~ is the only known promoter for transcription of the approximately 35 DNA transfer operon genes. It is regulated by the indicated host and plasmid encoded proteins. H-NS acts as a silencing factor whereas both ArcA (a.k.a. SfrA, host encoded) and TraJ (plasmid encoded) are needed for activation. Transcription of the complete operon additionally requires the host encoded anti-termination protein RfaH and its recognition site *ops* (operon polarity suppressor). Entry/surface exclusion genes *traS* and *traT* are constitutively transcribed in plasmid carrying cells. The transcriptional terminator (red hairpin) is functional only for transcripts initiating at promotor P~ST~. For a more in-depth discussion of DNA transfer genes and their regulation in MOB~F12~A plasmids, the reader is referred to a recent review ([@B9]). **(B)** A schematic overview of the P~Y~ promoter region of the MOB~F12~A prototype plasmid R1 from −241 to +156 relative to the transcription start site (+1, red arrow) of the *tra* operon is shown. This fragment is present in the promoter test plasmid pRSYZ4. Yellow bars with numbers indicating their location represent H-NS binding regions (I,II,III) as determined in this work. AT percentage of these regions is shown below. *abs*, binding site for ArcA; *jbs*, binding site for TraJ. These elements are also present on the 319 bp DNA fragment---termed R1P~Y~---used for EMSA and DNase I footprinting experiments (black line above). **(C)** Sequence representation of the P~Y~ promoter of MOB~F12~A plasmids R1 (KY749247), pSLT (AE006471), and F (AP001918). To access a complete plasmid sequence in the NCBI nucleotide database (<https://www.ncbi.nlm.nih.gov/nuccore>), please use the accession number provided in parentheses. The non-template DNA strand is shown. *abs* and *jbs* sites as determined in this work are given above the sequences for the plasmid R1 P~Y~ promoter. The tandem repeat for ArcA binding \[consensus: TGTTAA(N5)TGTTAA\] is highlighted in cyan and the *jbs* inverted repeat sequences are highlighted in green. −10, extended −10 (TG), −35 as well as the first transcribed nucleotide (+1) are highlighted in yellow.](fmicb-11-01254-g001){#F1}

The ability to transport DNA from donors into recipient cells requires the expression of DNA transfer genes. A variety of regulatory mechanisms ensure that only a few cells in a genetically homogeneous population undergo this developmental process and become transfer competent. Thereby, at the population level, negative consequences of transfer gene expression are reduced without compromising horizontal gene transfer to novel hosts ([@B10]; [@B22]). In F-like plasmids DNA transfer genes are controlled through a network of regulatory elements ensuring that under optimal conditions only a few cells in a population---approximately 0.1 to 1%---proceed to transfer competence ([@B7]; [@B10]). The key plasmid encoded activator that has to escape negative control is TraJ, a plasmid encoded protein. As schematically depicted in [Figure 1A](#F1){ref-type="fig"}, TraJ and chromosomally encoded ArcA proteins are absolutely required to overcome heat-stable nucleoid structuring (H-NS) protein silencing and to activate transcription of DNA transfer genes from the main transfer operon promoter P~Y~ ([@B27]; [@B24]; [@B14]).

Here we characterize DNA binding characteristics of these proteins and focus on defining the binding sites in the P~Y~ promoter region of plasmid R1 (TraJ~R1~), a conjugative resistance plasmid discovered 1963 in London in a clinical *Salmonella enterica* serovar Paratyphi B isolate ([@B4]). Originally named R~7268~, it was subsequently renamed R1 ([@B16]). Only recently the complete sequence of this plasmid has been determined ([@B3], accession: [KY749247](KY749247)). In order to characterize DNA binding, purified H-NS, ArcA, and TraJ~R1~ proteins were used in both electrophoretic mobility shift assays (EMSA) and DNase I footprinting experiments. EMSA revealed DNA binding by H-NS and TraJ with low sequence specificity, whereas ArcA binding to R1P~Y~ was highly sequence specific. In DNase I footprinting experiments, the TraJ~R1~ binding site (*jbs*) in the P~Y~ promoter region was found to span the region from −51 to −38, immediately adjacent to the ArcA binding site (*abs*), located at −76 to −60 (see [Figures 1B,C](#F1){ref-type="fig"}). Furthermore, TraJ and ArcA together were found to be capable of displacing the silencing factor H-NS from promoter proximal sites of the P~Y~ promoter region *in vitro*. In order to corroborate these findings, we mutated the proposed crucial sequence elements of the P~Y~ promoter and tested the mutants in a well-established reporter system. This approach confirmed the binding site for TraJ~R1~ in the region −51 to −38 and revealed that specificity for binding by TraJ solely resides in this locus. Second, it confirmed the essential contribution of ArcA in P~Y~ promoter activation and finally demonstrated that the non-canonical −35 element is important for control and regulation of P~Y~.

Materials and Methods {#S2}
=====================

Media, Growth Conditions, Bacterial Strains, Plasmids, and Oligonucleotides {#S2.SS1}
---------------------------------------------------------------------------

LB medium (L^--1^: 10 g tryptone, 5 g yeast extract, 5 g NaCl) or 2xTY medium (per liter: 16 g tryptone, 10 g yeast extract, and 5 g NaCl) was used. For β-galactosidase assays, cells were grown in M9 minimal salt medium ([@B17]); L^--1^: 3 g KH~2~PO~4~, 12.8 g Na~2~HPO~4~ × 7 H~2~O, 1 g NH~4~Cl, 0,5 g NaCl, 3 g casaminoacids; 0.1 mg/mL thiamin; 0.2% glucose; 1 mM MgSO~4~. If appropriate, antibiotics such as 40 μg mL^--1^ kanamycin, 20 μg mL^--1^ chloramphenicol, or 50 μg mL^--1^ ampicillin were added. Unless otherwise indicated, cultures were grown aerated in a shaker-incubator at 180 r/min and 37°C. Cell densities (OD~600~) were measured in a Hitachi U5100 spectrophotometer. *E. coli* strains and plasmids are listed in [Supplementary Table S1](#TS1){ref-type="supplementary-material"}; oligonucleotides obtained from eurofins Genomics (Ebersberg, Germany) used in this study are listed in [Supplementary Table S2](#TS1){ref-type="supplementary-material"}.

DNA Manipulations, Cloning, Sequencing, and Sequence Analyses {#S2.SS2}
-------------------------------------------------------------

DNA manipulations were done using standard techniques ([@B21]) or according to the manufacturers' recommendations. PCR reactions for cloning purposes were performed using Phusion High-Fidelity DNA Polymerase (New England BioLabs). Construction of expression plasmids for TraJ (pSD1002), TraJI~187T~ (pSD1002~I187T~), and H-NS (pSThns) are detailed in the [Supplementary Methods](#TS1){ref-type="supplementary-material"} section. ArcA was overproduced from plasmid pETarcA-1 ([@B23]). Mutations in the R1P~Y~-*lacZ* promoter test plasmid pRSYZ4 ([@B23]; [@B24]) were introduced according to a modified QuikChange protocol ([@B12]; [@B11]). TraJ expressing plasmids in the R1P~Y~ promoter activation studies were the same as used previously ([@B24]) except pJSlt2 containing the *traJ* gene from the *Salmonella enterica* plasmid pSLT. All resulting plasmids created in this study were verified by DNA sequencing using the Eurofins Genomics (Ebersberg, Germany) sequencing service. *In silico* construction of plasmids and sequence analysis was performed using SnapGene software.

Protein Expression and Purification {#S2.SS3}
-----------------------------------

ArcA protein containing an N-terminal His~6~ tag was purified using the method described and activated by phosphorylation before use in EMSA and DNase I footprintig assays ([@B23]). TraJ and His~6~-H-NS were produced and purified as described in the [Supplementary Material](#TS1){ref-type="supplementary-material"}.

DNA Fragments for EMSA and DNase I Footprinting Experiments {#S2.SS4}
-----------------------------------------------------------

All DNA fragments were amplified by PCR using 5′-Cy5-labeled primers as indicated. Primers and their sequences are listed in [Supplementary Table S2](#TS1){ref-type="supplementary-material"}. R1P~Y~ DNA (319 bp) from −253 to +66 relative to the transcription start site of the *tra* operon containing the 3′ end of the *traJ* gene, the previously established ArcA-P binding site ([@B23]), the predicted P~Y~ promoter ([@B23]), and the 5′ end of the *traY* gene ([Figure 1B](#F1){ref-type="fig"}) was amplified by PCR from *E. coli* harboring plasmid R1 using oligonucleotides PYTransfw, and PYTransrev1. For footprinting studies, only one of the two primers was 5′-Cy5-labeled. **GZ** DNA (261 bp) is a fragment generated from plasmid pGZ119EH DNA using oligonucleotides pTG-NF4-fw and pgzrev508. It roughly encompasses the *tac* promoter, the *lac* operator and the multiple cloning site of the plasmid. **FP~Y~** DNA (422 bp) was generated by PCR from *E. coli* XK1200 (pOX38-Km) and primers F_Py_fw and F_Py_rev. It contains DNA from −393 to +29 relative to the transcription start site of the F-plasmid *tra* operon. **Atu** DNA (395 bp) was generated by PCR from *Agrobacterium tumefaciens* C58 using primers GroEL_Atum_fw and GroEL_Atum_rev and covers a part of the *groEL* gene.

EMSA {#S2.SS5}
----

A Cy-5 labeled DNA fragment (0.5 nM) was mixed by pipetting on ice with varying concentrations of purified protein in band shift buffer (12 mM HEPES pH 7.9, 30 mM Tris-Cl pH 7.5, 60 mM KCl, 10% glycerol, 1.7 mM EDTA, 26 mM boric acid, 5 mM TCEP). Samples were placed in 0.2 mL PCR tubes; total reaction volume was 15 μL. Tubes were then transferred to a thermocycler and incubated at 30°C for 15 min. DNA and protein--DNA complexes were then electrophoretically separated on non-denaturing 6% polyacrylamide gels (PAGs; acrylamide:bisacrylamide 80:1, 2.5% glycerol, 0.07% APS, and 0.07% TEMED). Vertical electrophoresis was performed in Hoefer Mighty Small II chambers with TBE buffer (100 mM Tris base, 100 mM boric acid, 2.5 mM EDTA pH 8.3) with 20 mA at 4°C for 30--45 min. After disassembly of the electrophoresis unit, the gel was scanned using a Typhoon 9400 scanner (GE Healthcare). For image analysis and estimation of the dissociation constant, the Quantity One software (Bio-Rad) was used. Each band shift experiment was performed at least twice.

DNase I Footprinting {#S2.SS6}
--------------------

For the DNase I footprint experiment, the same 319 bp R1P~Y~ DNA fragment as described for EMSA experiments was used with the exception that only one DNA strand was Cy5-labeled. Binding reaction mixtures (50 μL total volume) contained 50 mM Tris-Cl pH 7.2, 100 mM KCl, 10% glycerol, 30 ng of P~Y~ DNA, and varying concentrations of TraJ, ArcA-P, or H-NS. To allow protein--DNA complex formation, P~Y~ DNA and proteins were incubated for 20 min at 4°C and 2 min at 25°C. 50 μL of a 10 mM MgCl~2~, 5 mM CaCl~2~ solution were added and incubated for 1 min. To digest the DNA 0.1 U DNase I (1 U/μL) (Fermentas) were added directly to the protein-DNA mixes and incubated for 2 min. The reaction was terminated with 90 μL stop solution (20 mM EDTA, 200 mM NaCl, 1% SDS, 250 μg/mL herring sperm DNA). DNA was precipitated by adding 2.5 volumes of ethanol (96%) and incubation for 3 h at −70°C. Precipitates were sedimented by centrifugation (15,000 × *g*, 10 min, RT), washed with 70% ethanol, and centrifuged as before. After removal of the supernatant, the pellets were air-dried and resuspended in 10 μL formamide loading dye (Thermo Sequenase Primer Cycle Sequencing Kit, GE Healthcare), denatured for 10 min at 95°C, and separated on a 8% polyacrylamide sequencing gel (ReproGel^TM^, High resolution, GE Healthcare) in an Alf Express Sequencer (GE Healthcare). The sequencing reactions of the P~Y~ DNA fragment were done with the Thermo Sequenase fluorescent-labeled Primer Cycle Sequencing Kit (GE Healthcare) using 200 ng of DNA and Cy-5 labeled primer PYTransfw or PYTransrev1. Data were analyzed using the AlfWin Sequence Analyzer software (Amersham Pharmacia Biotech).

R1P~Y~ Promoter Activation Tests {#S2.SS7}
--------------------------------

For these tests, *E. coli* MC4100 co-transformed with the P~Y~ promoter test plasmid pRSYZ4 (carrying a R1P~Y~-*lacZ* fusion) and *traJ* expressing plasmids (pJR1 or pJF or pJSLT2) or a vector control plasmid (pGZNSO2) were assayed for β-galactosidase activity. Promoter activation tests were similarly performed with derivatives of pRSYZ4 created by site specific mutagenesis. β-galactosidase assays were performed essentially as described previously ([@B24]) and according to an Open Wetware protocol^[1](#footnote1){ref-type="fn"}^ (last accessed 28/02/2020). Details of the procedure can be found in [Supplementary Material](#TS1){ref-type="supplementary-material"}.

Results {#S3}
=======

Binding of H-NS ArcA, and TraJ to R1P~Y~ DNA {#S3.SS1}
--------------------------------------------

In a previous study, we could show that H-NS is involved in silencing *tra* gene expression of plasmid R1 *in vivo* ([@B24]). We therefore set up experiments to investigate direct H-NS binding to a fluorescently labeled DNA fragment containing the R1 P~Y~ promoter (R1P~Y~ DNA, 319 bp, 62% AT) as shown in [Figure 1B](#F1){ref-type="fig"}. This DNA fragment was incubated with increasing concentrations of purified H-NS protein and the resulting DNA--protein complexes were separated electrophoretically on a non-denaturing PAG. As can be seen in [Figure 2A](#F2){ref-type="fig"}, H-NS bound to R1P~Y~ with high affinity producing a distinct complex visible at protein concentrations between 30 and 250 nM H-NS. Higher H-NS concentrations shifted the DNA to the top of the gel. We estimated an apparent dissociation constant *K*~*d*~ of 15 nM. However, as is clearly obvious from [Figure 2C](#F2){ref-type="fig"}, H-NS also bound to a control DNA fragment (GZ DNA, 261 bp, 49% AT). For a direct comparison in the DNA binding behavior, we performed binding studies using the same DNA fragments with phosphorylated ArcA protein (ArcA-P). The results are shown in [Figures 2B,D](#F2){ref-type="fig"}. Binding of ArcA-P to R1P~Y~ with apparent *K*~*d*~ of 60 nM is highly specific. ArcA-P only bound to R1P~Y~ containing the *abs* site shown in [Figure 1C](#F1){ref-type="fig"} but not to the GZ fragment which does not contain a binding motif for ArcA.

![Binding of H-NS and ArcA-P (phosphorylated ArcA) to R1P~Y~ (319 bp, 62% AT, see [Figure 1B](#F1){ref-type="fig"}) and control (GZ, 261 bp, 49% AT) DNA fragments. Electrophoretic mobility shift assays (EMSAs) were performed with the indicated fluorescently Cy5-labeled ds DNA fragments (0.5 nM) and purified proteins using the indicated protein concentrations (np: no protein present). Formed DNA--protein complexes were electrophoretically separated using non-denaturing polyacrylamide gels (PAGs) from free DNA and visualized by fluorescence imaging. Free DNA fragments are indicated at the bottom of the gels. Complexes appear as distinct bands, smear, or are retained in the gel slots. To increase perceptual contrast, images were inverted (gray fluorescence signal on a white background). **(A)** EMSA with purified H-NS protein and R1P~Y~ DNA. High affinity binding in with an apparent dissociation constant (*K*~*d*~) of about 15 nM can be observed. **(B)** EMSA with ArcA-P protein demonstrates binding of ArcA-P to R1P~Y~ with K~*d*~ of 60 nM. **(C)** H-NS binds to both R1P~Y~ and GZ DNA. **(D)** ArcA-P is highly specific and only binds to R1P~Y~ which contains the *abs* tandem repeat sequence as depicted in [Figure 1C](#F1){ref-type="fig"}.](fmicb-11-01254-g002){#F2}

In a second series of band shift experiments ([Figure 3](#F3){ref-type="fig"}), we wished to investigate the DNA binding properties of TraJ~R1~ which has been identified as an essential activator of the P~Y~ promoter and *tra* operon transcription of plasmid R1 ([@B24]). As can be seen in [Figure 3A](#F3){ref-type="fig"}, purified TraJ~R1~ bound to R1P~Y~ DNA; however, no distinct DNA--protein complexes appeared except that at concentrations \> 500 nM TraJ~R1~ R1P~Y~ DNA is shifted to the top of the gel. The apparent *K*~*d*~ was estimated to be 250 nM for binding of TraJ~R1~ to R1P~Y~ DNA. Importantly, the only protein found by mass spectroscopy in the top shifted band was TraJ~R1~ (data not shown). Thus, we exclude the presence of contaminating DNA binding proteins in our TraJ protein preparations. We previously identified a loss-of-function mutant of TraJ~R1~ (I187T); furthermore, ChIP experiments suggested that this mutant had severely disturbed the DNA binding capability ([@B24]). Consistent with these findings, purified TraJ~R1~ (I187T) displayed a considerably weaker DNA binding activity with an apparent *K*~*d*~ of 750 nM ([Figure 3B](#F3){ref-type="fig"}). To investigate the specificity of TraJ~R1~ DNA binding, we performed several DNA binding experiments. As can be seen in [Figure 3C](#F3){ref-type="fig"}, TraJ~R1~ also bound to FP~Y~ and Atu DNA fragments which do not contain the *jbs* recognition sequence ([Figure 1C](#F1){ref-type="fig"}). However, quantitation of the remaining free DNA in relation to total DNA at 500 nM TraJ~R1~ revealed only 17% in case of R1P~Y~, whereas there were 34 or 28% in case of FP~Y~ or Atu fragments, respectively. This result suggested that TraJ~R1~ bound with a higher affinity to R1P~Y~ (319 bp) when compared to FP~Y~ (422 bp) or a DNA fragment from *A. tumefaciens* (Atu, 395 bp). In another approach, TraJ~R1~ binding was investigated using two different DNA fragments (R1P~Y~ and GZ) simultaneously. Although not a strikingly clear difference (compare ArcA-P binding to the same fragments, [Figure 2D](#F2){ref-type="fig"}), there is a slight preference for the R1P~Y~ fragment ([Figures 3D,E](#F3){ref-type="fig"}). We finally found that pre-incubation of the DNA fragments (R1P~Y~ and GZ) with 250 nM ArcA-P increased TraJ~R1~ preference for R1P~Y~ DNA ([Figures 3F,G](#F3){ref-type="fig"}). Taken together, these results suggest that TraJ~R1~ has a DNA binding activity which is stronger when the cognate *jbs* site is present and that ArcA-P binding could direct TraJ~R1~ toward the DNA containing *jbs* next to *abs*.

![EMSAs with various proteins and DNA fragments to characterize TraJ~R1~ binding to DNA. Binding studies were analyzed as described in [Figure 2](#F2){ref-type="fig"}. np, no protein added. **(A)** TraJ~R1~ binds to R1P~Y~ DNA. No distinct DNA--protein complexes can be seen. The *K*~*d*~ is estimated from this EMSA is 250 nM. At concentrations \> 500 nM R1P~Y~ DNA is shifted to the gel slot. **(B)** An activation deficient TraJ~R1~ mutant (I187T) displays a considerably weaker DNA binding activity with an apparent *K*~*d*~ of 750 nM. **(C)** Comparison of TraJ~R1~ binding to different DNA fragments. TraJ~R1~ binds with higher affinity to R1P~Y~ (319 bp) when compared to FP~Y~ (422 bp) or a DNA fragment from *Agrobacterium tumefaciens* (Atu, 395 bp). **(D)** Simultaneous binding of TraJ~R1~ to R1P~Y~ and a control fragment (GZ). TraJ~R1~ binds with higher affinity to R1P~Y~ when compared to a control DNA. **(E)** The percentage of free R1P~Y~ DNA and GZ DNA from **D** was calculated and graphically represented relative to the DNA fluorescence of the respective fragment without protein. **(F)** Pre-incubation of the DNA fragments (R1P~Y~ and GZ) with 250 nM ArcA-P increases TraJ~R1~ preference for R1P~Y~ DNA. **(G)** The percentage of R1P~Y~ DNA bound to ArcA-P or free GZ DNA from **F** was calculated and graphically represented relative to the DNA fluorescence of the respective fragment without addition of TraJ~R1~. The difference between TraJ~R1~ binding to R1P~Y~-ArcA-P versus binding to GZ when compared to **E** is clearly increased. rfi: relative fluorescence intensity.](fmicb-11-01254-g003){#F3}

H-NS and TraJ~R1~ Binding Sites in the P~Y~ Promoter Region of Plasmid R1 {#S3.SS2}
-------------------------------------------------------------------------

Binding of ArcA-P to the R1 P~Y~ promoter region has been determined earlier by DNase I footprinting ([@B23]) and clearly demonstrated that ArcA-P can bind to the *abs* site indicated in [Figure 1C](#F1){ref-type="fig"}. To determine the binding sites for H-NS and TraJ~R1~, we again performed DNase I protection assays using the 319 bp R1P~Y~ DNA fragment either fluorescently labeled on the top (non-coding) or bottom (coding) strand. The result of such an experiment is shown in [Figure 4](#F4){ref-type="fig"} where the binding regions for H-NS appear as three distinct regions with reduced band intensities when compared to the control DNase I digest without protein. These regions are labeled H-NS I (−184 to −157, 81% AT), H-NS II (−126 to −78, 77% AT), and H-NS III (−69 to + 4, 66% AT). The banding pattern changes when proteins ArcA-P and TraJ~R1~ are additionally present (lane A + J + H in [Figure 4](#F4){ref-type="fig"}), suggesting a replacement of H-NS by ArcA-P and TraJ~R1~. The binding sites for ArcA-P and TraJ~R1~ are indicated in [Figure 4](#F4){ref-type="fig"} and correspond to *abs* and *jbs* sequence motifs shown in [Figure 1C](#F1){ref-type="fig"}.

![DNase I footprinting of the R1P~Y~ dsDNA fragment with the non-template strand fluorescently labeled reveals binding sites for H-NS, ArcA-P, and TraJ~R1~ in the R1P~Y~ promoter region. Lanes A, C, G, and T are products of sequencing reactions with some of the bases indicated on the left side of lane A. np, DNA fragments obtained with DNase I digestion. H, DNA fragments obtained with 0.2 μM H-NS before DNase I digestion. Three distinct regions with reduced band intensities are indicated by yellow bars. H-NS protected regions are indicated on the left side and correspond to three AT rich regions as shown in [Figure 1B](#F1){ref-type="fig"}. Last lane shows DNase I fragments obtained in the presence of ArcA-P (0.4 μM), TraJ~R1~ (5 μM), and H-NS (0.2 μM). The resulting change in the banding pattern suggests a replacement of H-NS from binding site III and partially from binding site II. Note the appearance of an additional prominent band between −35 and −10 regions in the P~Y~ promoter (indicated by an asterisk). *abs*, binding site for ArcA-P; *jbs*, binding site for TraJ~R1~.](fmicb-11-01254-g004){#F4}

To better define the binding site for TraJ~R1~ further DNase I footprinting experiments were performed with increasing TraJ~R1~ concentrations, ArcA-P alone and TraJ~R1~ together with ArcA-P. As shown in [Figures 5A,D](#F5){ref-type="fig"} (top strand labeled) TraJ~R1~ protected from DNase I cleavage at positions A-57 and C-90. Protection of C-90 by TraJ~R1~ indicates a secondary binding site in R1P~Y~ which is located outside the proposed *jbs* recognition site. This can be attributed to the sequence independent DNA binding activity of TraJ~R1~ which was also evident in the band shift experiments. ArcA-P protected T-74. Positions A-57 and T-74 are consistent with the proposed *jbs* and *abs* recognition sites, respectively. Addition of both proteins produced a protection pattern indicating simultaneous DNA binding of TraJ~R1~ and ArcA-P. On the bottom strand TraJ~R1~ protected from DNase I cleavage at position A-42. ArcA-P protected at T-72 and A-76 ([Figures 5B,C](#F5){ref-type="fig"}). Again, these positions are consistent with the proposed *jbs* and *abs* motifs. From these results, we deduce that the recognition site for TraJ~R1~ (*jbs*) in the R1P~Y~ promoter extends from −51 to −38 and includes the imperfect inverted repeat sequence [CGCCAA]{.ul}TT[TTGGCG]{.ul} with two non-palindromic bases (TT) in the center. Incubation of R1P~Y~ DNA with ArcA-P alone resulted in the expected protection of the direct repeats [TGTTAA]{.ul}GTAAA[TGTTAA]{.ul} from −76 to −60. Binding of ArcA-P to this site has been shown by our group previously ([@B23]). This sequence closely resembles the proposed recognition matrix for ArcA-P in *E. coli* ([@B13]; [@B19]). In addition, the sequence motif is highly conserved in P~Y~ promoter sequences of F-like plasmids.

![DNase I protection pattern by TraJ~R1~ and ArcA-P obtained on R1P~Y~ DNA. R1P~Y~ DNA fluorescently 5′-labeled on the non-template **(A)** or the template **(B)** strand was incubated with proteins as indicated and subsequently digested with DNase I. The resulting DNA fragments were separated on a denaturing PAG. A gel-like image of the detected fluorescence signals is shown in **A,B**. Lanes A, C, G, and T are products of sequencing reactions. For orientation, some bases are indicated on the left side of lane A, respectively. Proteins were added before DNase I digestion as follows: J: TraJ~R1~ 0.5, 2, or 5 μM; A: ArcA-P 0.27 or 0.55 μM. J + A: TraJR1 + ArcA-P, 2 and 0.27 μM, respectively. np, no protein added before DNase I digestion. A: TraJ~R1~ protects from DNase I cleavage at positions A-57 and C-90. ArcA-P protects T-74. Positions A-57 and T-74 are consistent with the proposed *jbs* and *abs* recognition sites as shown in **C**, respectively. Addition of both proteins produces a protection pattern indicating simultaneous DNA binding of TraJ~R1~ (indicated by a green bar) and ArcA-P (magenta bar). **(B)** TraJ~R1~ protects from DNase I cleavage at position A-42. ArcA-P protects T-72 and A-76. These positions are consistent with the proposed *jbs* and *abs* regions as shown in **C**, respectively. Addition of both proteins produces a protection pattern indicating simultaneous DNA binding. **(C)** DNA sequences of non-template (top) and template (bottom) DNA strands from the R1P~Y~ promoter region (−76 to −7). The proposed *abs* (−76 to −60) and *jbs* (−51 to −38) sites are indicated above the sequence. Open triangles indicate bases protected by ArcA-P and filled triangles represent ArcA-P induced DNase I cleavage sites. Open circles indicate bases protected by TraJR1 and filled circles represent TraJ~R1~ induced DNase I cleavage sites. + 1: transcription start site as determined by reverse transcription of *tra* mRNA, −10: −10 region of the P~Y~ promoter, TG: extended −10 motif. **(D)** Curve view of DNase I footprinting experiment shown in **A**. Proteins were added as indicated. np, no protein added before DNase I treatment.](fmicb-11-01254-g005){#F5}

P~Y~ Promoter Sequence Requirements for TraJ Activation {#S3.SS3}
-------------------------------------------------------

The *in vitro* results demonstrated that TraJ~R1~ can bind to DNA. Based on the above described preference for *jbs* containing DNA and the DNAse I footprinting data, we concluded that TraJ~R1~ specifically recognizes an inverted repeat sequence in the P~Y~ promoter including bases from −51 to −38 in the R1P~Y~ promoter region. This is consistent with previous results of ChIP experiments where we could demonstrate specific *in vivo* binding of TraJ~R1~ to the R1P~Y~ DNA ([@B24]). We also noted that sequences in the P~Y~ promoter region between different subclasses of F-like plasmids differ as do the cognate TraJ proteins ([@B24]; [@B9]). To verify the *jbs* recognition sequence and to demonstrate subclass-specific activation of the P~Y~ promoter of F-like plasmids, we systematically mutagenized the *jbs* site in the R1P~Y~ promoter and tested its activation by TraJ proteins from plasmid R1, pSLT, or F. The mutations shown in [Figure 6A](#F6){ref-type="fig"} were introduced in the promoter test plasmid pRSYZ4 in which the R1P~Y~ promoter is fused to the *lacZ* reporter gene. β-Galactosidases assays were performed to evaluate basal promoter activity (with a vector control plasmid) and its activation by the above mentioned TraJ proteins. As can be seen in [Figure 6B](#F6){ref-type="fig"}, there was a very low basal expression level from the R1P~Y~ promoter which could be induced by both TraJ~R1~ and TraJ~pSLT~ but not by TraJ~F~. In the fully stimulated promoter expression was about 6.5-fold to 8-fold higher than the basal expression. The mutation of three bases (m1) in *jbs* did not change the basal expression level but completely abolished activation by TraJ~R1~ showing that these bases in *jbs* are absolutely essential for recognition by TraJ~R1~. There was no activation by TraJ~F~. Further sequential mutations toward the F *jbs* did not change this phenotype dramatically (m4, m41). However, finally, mutants with an almost completely changed *jbs* sequence (m42, m43) displayed a specificity switch. The P~Y~ promoter in these mutants was activated by TraJ~F~ and not by TraJ~R1~. We also observed an approximately twofold increase in the basal P~Y~ promoter activity in mutant m43 which could be activated by TraJ~F~ fourfold ([Figure 6](#F6){ref-type="fig"}).

![Determination of important sequence elements in the R1P~Y~ promoter for activation by TraJ~R1~. Successively introduced mutations switch recognition specificity to TraJ~F~. **(A)** Sequences showing sequentially created site specific mutations in R1P~Y~. Top line shows the R1P~Y~ wt sequence with the *abs* and *jbs* sites indicated above. Bottom line shows FP~Y~ wt sequence with bases that differ from R1P~Y~ in bold letters. **(B)** β-Galactosidase assays with bacterial cells harboring a R1P~Y~-*lacZ* promoter-test plasmid and a second compatible plasmid IPTG-inducible for expression of *traJ* from plasmids R1 (JR1), F (JF), or pSLT (JSlt2); vc, vector control (no *traJ*). IPTG (inductor): +(added), −(not added). Mean values and standard deviations were calculated from at least three independently carried out experiments with two technical replicates for each experiment. *P*-values (paired *t*-test): \*\**P* \< 0.01; \*\*\**P* \< 0.001.](fmicb-11-01254-g006){#F6}

Another series of mutations was introduced into the R1P~Y~ promoter to investigate the effects of exchanges in *abs* and the −35 region ([Figure 7](#F7){ref-type="fig"}). In the m6 mutation in which the second TGTTAA ArcA recognition motif in *abs* is changed to TCATAA, we observed a reduced basal expression level (approximately 50% of the wt promoter) and a complete loss of its activation by TraJ~R1~. This is consistent with earlier R1P~Y~ promoter activity determinations using *arcA* mutant strains ([@B24]). Interestingly, there is some promoter activation by TraJ~pSLT~ which is probably due to a somewhat higher expression of this protein variant (data not shown). The −35-region mutant (TTTTTT to TTGATT) unexpectedly led to a complete different of the R1~PY~ promoter behavior. First, the basal expression level was higher than from the wt promoter in the fully induced state, second, there was no observable induction by TraJ, and third, there was no more dependence on ArcA since the abs site mutation had no effect on the high expression level. Thus, by introducing just two bases making the −35 sequence more similar to the canonical −35 recognition sequence (TTGACA) which is contacted by region 4 of the σ^70^ subunit of the RNA polymerase converted the R1P~Y~ promoter into a constitutive and completely deregulated promoter.

![Determination of the role of *abs* and the non-canonical −35 region in the R1P~Y~ promoter. **(A)** Top line shows the R1P~Y~ wt sequence with the *abs* and *jbs* sites indicated above. Mutations tested in β-galactosidase assays are shown in the R1P~Y~ sequence context and highlighted in red. **(B)** β-Galactosidase assays with bacterial cells harboring a R1P~Y~-*lacZ* promoter-test plasmid and a second compatible plasmid IPTG-inducible for expression of *traJ* from plasmids R1 (JR1), F (JF), or pSLT (JSlt2). vc: vector control (no *traJ*). IPTG (inductor): +(added), -(not added). Mean values and standard deviations were calculated from at least three independently carried out experiments with two technical replicates for each experiment. *P*-values (paired *t*-test): \*\*\**P* \< 0.001.](fmicb-11-01254-g007){#F7}

Discussion {#S4}
==========

Expression of the *tra* operon is an absolute requirement for bacteria carrying CPs to develop transfer competence. Only transfer competent cells which usually only represent a minor subpopulation of plasmid harboring cells can actively transfer DNA into recipients and thereby spread genes horizontally in bacterial populations. Intricate genetic regulatory networks ensure that transfer genes are expressed only under optimal conditions ([@B7]; [@B10]; [@B22]). Here, we investigated the molecular basis of *tra* gene activation of the classical antibiotic resistance plasmid R1 which belongs to a large family of F-like plasmids, also categorized as MOB~F12~A ([@B6]). The performed experiments are based on a previous study where we genetically characterized the contribution of *hns*, *arcA*, and *traJ* on silencing and activating DNA transfer and type IV secretion genes of plasmid R1 ([@B24]). H-NS binding to the R1P~Y~ promoter DNA could be directly shown by EMSA and DNase I footprinting experiments. As expected, DNA binding by H-NS was not specific for the R1P~Y~ promoter but also bound to a control DNA fragment in the EMSA with a lower AT content. However, the observed apparent *K*~*d*~ with the R1P~Y~ fragment was very low (15 nM) and comparable to DNA fragments containing nucleation sites for H-NS such as *csgD* or *proU* promoters ([@B1]; [@B8]). In the DNase I protection experiment, we identified three AT binding regions in the R1P~Y~ promoter region (H-NS I, H-NS II, and H-NS III). Due to their high AT content of 81 and 77%, the first two could serve as nucleation sites since this high AT content represents the documented preferred composition of H-NS targets *in vivo* ([@B18]). Our results are fully consistent with the proposed silencing role of *hns* in *tra* gene expression of plasmid R1 ([@B24]).

Counter-silencing functions of the known activators of *tra* gene expression ArcA (the response regulator of the ArcAB two component system) and TraJ, requires displacement of H-NS from at least the H-NS III binding region which could facilitate RNA polymerase access to −35 and −10 regions of the P~Y~ promoter. *In vitro* binding of ArcA-P and *in vivo* activation functions have been established earlier suggesting that these proteins could help clearing the promoter from H-NS and recruiting RNA polymerase ([@B23]; [@B24]). The EMSA results confirmed specific ArcA-P binding the R1P~Y~ promoter, in addition TraJ~R1~ bound to DNA but only with a slight preference for R1P~Y~ DNA. DNase I footprinting analysis nevertheless revealed a protection pattern for TraJ~R1~ that is consistent with the proposed *jbs* site with the inverted repeat sequence located between −51 and −38 and confirmed ArcA-P binding immediately next to TraJ~R1~ to two direct repeats from −76 to −60. The TGTTAA hexamer represents the core of the ArcA sequence motif with the highest conservation. In most *E. coli* ArcA regulated promoters, two or three direct repeats of these ArcA boxes are found ([@B19]). Since the simultaneous addition of both proteins can change the protection pattern of H-NS in a way that suggests replacement of H-NS by ArcA and TraJ from binding site III and partially from binding site II ([Figure 4](#F4){ref-type="fig"}), we propose that such a mechanism is responsible for the observed *in vivo* activation of R1P~Y~ by ArcA and TraJ. Phosphorylated ArcA may be responsible for a first counter-silencing activity and opening the P~Y~ promoter for TraJ activator binding in a second step. It has similarly been shown that the SsrB response regulator of *S. enterica* can replace H-NS from type III effector gene promoters in SPI-2 required for intracellular growth and maintenance of this pathogen ([@B26]). A cooperative activity of TraJ~F~ and ArcA has also recently been proposed to mediate activation of the FP~Y~ promoter which is also silenced by H-NS ([@B27]; [@B20]; [@B14]). The results of our promoter mutagenesis studies fully supported the idea that counter-silencing in the R1P~Y~ promoter requires ArcA since when only two bases in the second ArcA box hexamer were exchanged (from TGTTAA to T**CA**TAA), together with a lower basal activity, induction of the R1P~Y~ promoter was virtually abolished. On the other hand, silencing required a non-canonical −35 hexamer (TTTTTT) which when mutated to TT**GA**TT completely disrupted silencing an converted the mutant promoter into a constitutive promoter independent of both ArcA and TraJ. We envision that this mutation disrupts binding of H-NS in H-NS III of the R1P~Y~ promoter and at the same time allows binding of the RNA polymerase holoenzyme (with σ^70^) to productively initiate transcription from R1 P~Y~.

Although the role of the plasmid encoded activator protein TraJ is well established, the exact mechanism how TraJ acts at the molecular level is still unclear. Whereas the EMSA experiments showed DNA binding with an apparent dissociation constant *K*~*d*~ of about 250 nM only revealed a weak preference for R1P~Y~ fragment which was somewhat enhanced by ArcA. Clearly, as shown in the DNase I footprints, TraJ was able to bind next to ArcA in the R1P~Y~ promoter. However, there was also a prominent protected band outside the TraJ recognition motif *jbs* suggesting binding to DNA outside of *jbs* (C-90 in [Figure 5](#F5){ref-type="fig"}). Unspecific DNA binding was also observed in the band shift experiments and is possibly due to our *in vitro* conditions which do not reflect the true *in vivo* situation. Weak DNA binding and low specificity have also been observed for TraJ~F~ binding to the FP~Y~ promoter; in addition, the authors of that study suggested a cooperative binding mode without a direct protein-protein interaction ([@B14]). Our findings that ArcA-P binding to R1P~Y~ DNA somehow enhanced TraJ~R1~ binding to *jbs* containing DNA is consistent with this notion. Although we observed no direct protein-protein interaction between TraJ~R1~ and ArcA (data not shown), cooperativity between ArcA and TraJR1 could also be an important aspect of R1P~Y~ activation. Furthermore, results of several experiments suggest a direct interaction of TraJ with RNA polymerase (G. Koraimann, unpublished observations). Such a complex may strongly enhance affinity and sequence specificity. Investigations to better understand the interaction and complex formation between TraJ and the RNA polymerase of *E. coli* are currently ongoing in our laboratory.

In stark contrast to the *in vitro* observations are the results of R1P~Y~ promoter mutations in *jbs* and the effects of these mutations on the activation potential by TraJ~R1~ or TraJ~F~. The sequence identity between these two TraJ variants is only 18%---explaining the observed specificity of these activators, which means that TraJ~R1~ activates only the R1~PY~ promoter whereas TraJ~F~ only functions to activate the FP~Y~ promoter containing the cognate *jbs* site ([@B24]; [@B15]). Based on TraJ sequence variations within the MOB~F12~A family of F-like plasmids, nine subgroups have been recently proposed, presumably resulting in a subgroup-specific activation of the P~Y~ promoter ([@B9]). Two groups that share a rather high identity in the TraJ protein sequence (73%) are the R1 subgroup and the pSLT subgroup. As we demonstrate here, TraJ~R1~ and TraJ~pSLT~ are exchangeable. Furthermore, there are only a few bases that differ in the respective promoter sequences ([Figure 1](#F1){ref-type="fig"}). Exchanges of these bases, mostly outside of *jbs* did not affect silencing nor activation by TraJ~R1~ or TraJ~pSLT~ ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). However, when *jbs* in R1P~Y~ was mutated in only three positions of the inverted repeat sequence, we immediately observed a loss of activation by TraJ~R1~ indicating that recognition by TraJ *in vivo* is extremely specific. After a series of mutations toward the *jbs* sequence in FP~Y~, we finally observed a specificity switch, as the promoter was activated by TraJ~F~ and not by TraJ~R1~. This result shows that the sole determinant for recognition by TraJ resides in the identified *jbs* sequence.
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